moaB-II; ordered locus PP_4600 (EMBL AAN70173.1).The gene symbol, organism, protein family and domain architecture retrieved from UniProt are mutually consistent: moaB-II denotes a moaB paralog ("copy II") of the molybdenum-cofactor (Moco) biosynthesis protein B in P. putida. Literature on the MoaB/Mog family (E. coli MoaB/MogA, archaeal MoaB, plant Cnx1, gephyrin) aligns with the domain/family assignment. No literature describes a different, unrelated gene under this symbol that would create ambiguity. The caveat is not mis-identification but evidence type: there is no primary experimental study of the P. putida protein Q88E67 itself; its annotation is by homology to characterized family members.
Q88E67/MoaB-II is a small (~19 kDa) cytoplasmic protein of the MoaB/Mog family, a paralog of MogA, predicted to participate in the terminal steps of molybdenum-cofactor (Moco) / molybdopterin biosynthesis. The MogA branch of this family catalyzes the Mg²⁺/ATP-dependent adenylylation of molybdopterin (MPT → MPT-AMP), the activated intermediate from which molybdenum is inserted (by MoeA) to complete Moco. However, MoaB-type proteins — including Q88E67 by its UniProt annotation — bind molybdopterin (and GTP) but lack MPT-adenylyltransferase activity, and in E. coli MoaB is genetically dispensable for Moco synthesis. MoaB-II is therefore best described as a MogA-like pterin/nucleotide-binding protein of the Moco pathway whose precise catalytic role is enigmatic and probably accessory/redundant, acting in the cytoplasm.
The MoaB/Mog family unites bacterial MogA and MoaB, the plant multidomain protein Cnx1 (C-terminal G-domain), the animal protein gephyrin (G-domain), and Drosophila Cinnamon. Genetic complementation first showed that the C-terminal domain of Cnx1 "is homologous to the E. coli Moco proteins MoaB and MogA" and that these proteins act in "the last step of Moco biosynthesis, that is, the insertion of molybdenum into molybdopterin" (Stallmeyer et al., 1995, PMID 8528286). Structural work confirmed all family members are "involved in the insertion of an unknown molybdenum species into molybdopterin to form the molybdenum cofactor" (Bader et al., 2004, PMID 15159566).
Mechanistically, the reaction proceeds in two steps: the MogA/G-domain first adenylylates molybdopterin, and MoeA/E-domain then uses this MPT-AMP intermediate plus molybdate to insert Mo. Bevers et al. (2008) demonstrated directly that the MogA-type activity "catalyzes the adenylylation of MPT in a Mg2+ and ATP-dependent way" (PMID 18154309). Structural work on the eukaryotic G-domains confirms the chemistry and the intermediate: the plant Cnx1 G domain produces "adenylated molybdopterin (molybdopterin-AMP), a mechanistically important intermediate... subsequently processed in a magnesium-dependent reaction by the amino-terminal E domain of Cnx1 to yield active molybdenum cofactor" (Kuper et al., 2004, PMID 15306815), and in human gephyrin the "N-terminal G domain (GephG)" catalyzes "the penultimate adenylation of molybdopterin (MPT)" while the E domain performs "deadenylation as well as molybdate binding and insertion" (Kasaragod & Schindelin, 2016, PMID 27112598). These G domains are homologous to E. coli MogA (Schwarz et al., 2001, PMID 11554796) — the paralog family to which MoaB-II belongs. In P. putida the corresponding molybdate-insertion enzyme is MoeA (PP_2123), annotated to catalyze "the insertion of molybdate into adenylated molybdopterin with the concomitant release of AMP."
Although MoaB and MogA are close structural paralogs, they are functionally non-equivalent. In the same study, "only MogA is able to catalyze MPT adenylylation, whereas E. coli MoaB is inactive" (Bevers et al., 2008, PMID 18154309). The UniProt functional annotation of Q88E67 mirrors this precisely:
"May be involved in the biosynthesis of molybdopterin. Can bind GTP and has low GTPase activity. Can bind MPT, but has no MPT adenylyl transferase activity." (UniProt Q88E67, ARBA ECO:0000256)
Substrate/ligand specificity (by annotation transfer): binds molybdopterin (MPT) and GTP (nucleotide-binding, GTP-binding keywords), with only low GTPase activity and no adenylyltransferase catalysis. It therefore appears to retain the pterin/nucleotide-binding pocket of the MogA scaffold without performing the defining MogA chemistry.
In E. coli, the physiological role of MoaB has remained "enigmatic": transposon insertions in moaB caused partial Moco-deficiency (likely polar effects on the moaABCDE operon), but "in-frame deletions of moaB, or moaB overexpression, had no effect on either phenotype," data "consistent with the lack of any role for MoaB in Moco biosynthesis in E. coli" (Kozmin & Schaaper, 2013, PMID 23680484). This supports interpreting MoaB-II as dispensable/redundant or specialized rather than catalyzing an essential, unique step. The "-II" designation indicates P. putida encodes more than one MoaB-type protein, consistent with paralog redundancy or subfunctionalization.
Enumerating the MoaB/Mog family in the P. putida KT2440 proteome (UniProt, taxon 160488) returns exactly two members: moaB-I (Q88L15, 179 aa, PP_2122) and moaB-II (Q88E67, 172 aa, PP_4600). Notably, the proteome contains no gene annotated as MogA / molybdopterin adenylyltransferase (0 hits), although it does encode the downstream MoeA (Q88L14, PP_2123) and MobA (Q88HA3, molybdenum cofactor guanylyltransferase).
Pairwise global alignments (Needleman–Wunsch, identity scoring) place moaB-II firmly in the MoaB clade, not the MogA clade:
| Comparison | % identity |
|---|---|
| MoaB-II (Q88E67) vs E. coli MoaB (P0AEZ9) | 55.2% |
| MoaB-II (Q88E67) vs E. coli MogA (P0AF03) | 27.7% |
| MoaB-II vs MoaB-I (Q88L15) | 72.6% |
| E. coli MoaB vs MogA (reference) | 30.3% |
Because E. coli MoaB is the enzymatically inactive paralog and MoaB-II is ~55% identical to it (but only ~28% to the active MogA), sequence evolution independently supports the annotation that MoaB-II lacks MogA-type adenylyltransferase activity. MoaB-I and MoaB-II are 73% identical to each other, indicating a gene-duplication origin. Genomic context reinforces a division of labour: moaB-I (PP_2122) is immediately adjacent to moeA (PP_2123) — the two forming a syntenic Mo-insertion module — whereas moaB-II (PP_4600) sits at a separate, distant locus, most parsimoniously an accessory/duplicate copy.
MoaB proteins adopt a modified Rossmann fold and oligomerize. The 1.6 Å E. coli MoaB structure showed the protein is "assembled into a hexamer composed of two trimers" whose monomers have "high structural similarity with two proteins, MogA and MoeA," and with the G-domains of gephyrin and Cnx1; a putative active site was identified (Sanishvili et al., 2004, PMID 15269205). A second structure described a "32-symmetric hexamer" with a fold "similar to those of the MogA protein of E. coli, the G-domains of rat and human gephyrin and the G-domains of Cnx1 protein from A. thaliana" (Bader et al., 2004, PMID 15159566). Archaeal MoaB (ST2315) likewise forms trimers/hexamers with a fold "similar to those of other enzymes... involved in the molybdopterin- and molybdenum cofactor-biosynthesis pathways" (Antonyuk et al., 2009, PMID 20054111).
At 172 aa, Q88E67 is the size of a single MogA/G-type domain and is expected to fold identically and present the conserved pterin-binding pocket, most likely assembling into a trimer/hexamer. This is structural/bioinformatic evidence supporting the pathway assignment.
Moco biosynthesis is a cytoplasmic process, and the soluble MoaB/Mog-family proteins act there. Consequently MoaB-II is predicted to function in the cytoplasm, where it can access molybdopterin/MPT intermediates and nucleotides. No experimental localization for Q88E67 is available; the assignment follows from the pathway's known compartment and the protein's soluble, cofactor-binding nature.
A sequence-topology analysis performed here corroborates a soluble cytoplasmic protein: Kyte–Doolittle hydropathy (window 19) peaks at only 1.47 with no window exceeding the ~1.6–1.8 transmembrane threshold (zero predicted TM helices); the N-terminus lacks a cleavable Sec/Tat signal-peptide architecture (its hydrophobic start is the first β-strand of the Rossmann fold); and the protein has balanced charge (19 Asp+Glu vs 18 Lys+Arg) and near-neutral GRAVY (+0.137) — hallmarks of a soluble globular cytoplasmic enzyme rather than a membrane or secreted protein.
MoaB-II sits within cofactor biosynthesis → molybdopterin/Moco biosynthesis (UniProt PATHWAY annotation). This pathway is metabolically important in P. putida, which deploys numerous Moco-dependent molybdenum hydroxylases. Examples include the molybdopterin-cytosine-dinucleotide (MCD)-dependent enzymes of nicotine and N-heterocycle catabolism — where "a novel gene, PPS_4397 encoding moaE, is necessary for molybdopterin cytosine dinucleotide biosynthesis" (Jiang et al., 2015, PMID 26304596) and the 3-succinoylpyridine step uses "molybdenum molybdopterin cytosine dinucleotide as a cofactor" (Tang et al., 2013, PMID 24204321) — as well as quinoline/isoquinoline 2-oxidoreductases expressed in KT2440 (PMID 12654012, 12023088, 12730200) and heterologous xanthine oxidase (PMID 41933999). The Moco pathway that MoaB-family proteins support therefore underpins P. putida's catabolic versatility toward aromatic and N-heterocyclic compounds and purine oxidation. The report deliberately does not attribute broad pleiotropic phenotypes to MoaB-II specifically, given the E. coli evidence that MoaB deletion is phenotypically silent.
Supported (by homology + family biochemistry/structure):
- Q88E67 belongs to the MoaB/Mog family and acts in the cytoplasmic Moco/molybdopterin biosynthetic pathway.
- It binds molybdopterin and GTP and adopts a MogA-like G-domain fold (likely oligomeric).
- It does not possess the MogA MPT-adenylyltransferase activity (per its annotation and E. coli MoaB biochemistry).
Open / not established:
- The exact physiological reaction (if any) uniquely catalyzed by MoaB-II. In E. coli, MoaB is dispensable; whether P. putida MoaB-II is redundant, conditionally required, or subfunctionalized (e.g., under specific Mo/W or substrate conditions) is untested.
- P. putida KT2440 encodes no canonical MogA, so which protein supplies the adenylated-MPT (MPT-AMP) substrate that MoeA consumes is unresolved — candidates are latent activity of a MoaB paralog or a molybdate-concentration-dependent bypass (MogA is non-essential in E. coli).
- Direct experimental data on Q88E67 (activity assays, structure, deletion phenotype, localization) — none exist; all statements are inferences.
PP_4600 deletion and test Moco-dependent phenotypes (nitrate reductase/chlorate resistance, molybdoenzyme activities) alone and in combination with the other P. putida moaB/mogA paralog(s); (ii) in vitro assays for MPT adenylyltransferase and GTPase activity of purified Q88E67; (iii) solve the structure / AlphaFold-model the pterin/nucleotide pocket and compare to MogA vs. E. coli MoaB to identify residues explaining loss of adenylyltransferase activity; (iv) test conditional requirement under Mo limitation or tungsten substitution.